Helen Rubinstein | IR |
Barry Greene | CEO |
Albert Robichaud | Chief Scientific Officer |
Chris Benecchi | Chief Business Officer |
Kimi Iguchi | CFO |
Ritu Baral | Cowen |
Paul Matteis | Stifel |
Ami Fadia | Needham |
Jay Olson | Oppenheimer |
Swapnil Malekar | Piper Sandler |
Yatin Suneja | Guggenheim |
Marc Goodman | SVB Leerink |
Gospel Enyindah-Asonye | Morgan Stanley |
Gary Nachman | BMO |
Neena Bitritto-Garg | Citi |
Stephen Mallon | RBC Capital Markets |
Alex Nackenoff | Raymond James |
Good morning. Welcome to Sage Therapeutics' Second Quarter 2022 Financial Results Conference Call. Currently, all participants are in listen-only mode. This call is being webcast live on the Investors and Media section of Sage’s website at sagerx.com. This call is the property of Sage Therapeutics and recording, reproduction, or transmission of this call without the expressed written consent of Sage Therapeutics is strictly prohibited.